Tarsus Pharmaceuticals (TARS) PT Raised to $65 at Raymond James Following Positive TP-03 Survey
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: TARS) | Delayed: 68.20 -3.88 (5.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.08 | 52 Week High | $ | |||
| Open | $71.48 | 52 Week Low | $ | |||
| Day High | $71.71 | P/E | N/A | |||
| Day Low | $67.65 | EPS | $ | |||
| Volume | 556,620 | |||||
